• Something wrong with this record ?

Anticancer activity of natural cytokinins: a structure-activity relationship study

J. Voller, M. Zatloukal, R. Lenobel, K. Dolezal, T. Béres, V. Krystof, L. Spíchal, P. Niemann, P. Dzubák, M. Hajdúch, M. Strnad

. 2010 ; 71 (11-12) : 1350-9. [pub] 20100601

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Cytokinin ribosides (N(6)-substituted adenosine derivatives) have been shown to have anticancer activity both in vitro and in vivo. This study presents the first systematic analysis of the relationship between the chemical structure of cytokinins and their cytotoxic effects against a panel of human cancer cell lines with diverse histopathological origins. The results confirm the cytotoxic activity of N(6)-isopentenyladenosine, kinetin riboside, and N(6)-benzyladenosine and show that the spectrum of cell lines that are sensitive to these compounds and their tissues of origin are wider than previously reported. The first evidence that the hydroxylated aromatic cytokinins (ortho-, meta-, para-topolin riboside) and the isoprenoid cytokinin cis-zeatin riboside have cytotoxic activities is presented. Most cell lines in the panel showed greatest sensitivity to ortho-topolin riboside (IC(50)=0.5-11.6 microM). Cytokinin nucleotides, some synthesized for the first time in this study, were usually active in a similar concentration range to the corresponding ribosides. However, cytokinin free bases, 2-methylthio derivatives and both O- and N-glucosides showed little or no toxicity. Overall the study shows that structural requirements for cytotoxic activity of cytokinins against human cancer cell lines differ from the requirements for their activity in plant bioassays. The potent anticancer activity of ortho-topolin riboside (GI(50)=0.07-84.60 microM, 1st quartile=0.33 microM, median=0.65 microM, 3rd quartile=1.94 microM) was confirmed using NCI(60), a standard panel of 59 cell lines, originating from nine different tissues. Further, the activity pattern of oTR was distinctly different from those of standard anticancer drugs, suggesting that it has a unique mechanism of activity. In comparison with standard drugs, oTR showed exceptional cytotoxic activity against NCI(60) cell lines with a mutated p53 tumour suppressor gene. oTR also exhibited significant anticancer activity against several tumour models in in vivo hollow fibre assays.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026336
003      
CZ-PrNML
005      
20130520133041.0
007      
ta
008      
120817e20100601xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.phytochem.2010.04.018 $2 doi
035    __
$a (PubMed)20553699
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Voller, Jiří. $7 _AN043406 $u Laboratory of Growth Regulators, Palacký University and Institute of Experimental Botany ASCR, Slechtitelů 11, 783 71 Olomouc, Czech Republic.
245    10
$a Anticancer activity of natural cytokinins: a structure-activity relationship study / $c J. Voller, M. Zatloukal, R. Lenobel, K. Dolezal, T. Béres, V. Krystof, L. Spíchal, P. Niemann, P. Dzubák, M. Hajdúch, M. Strnad
520    9_
$a Cytokinin ribosides (N(6)-substituted adenosine derivatives) have been shown to have anticancer activity both in vitro and in vivo. This study presents the first systematic analysis of the relationship between the chemical structure of cytokinins and their cytotoxic effects against a panel of human cancer cell lines with diverse histopathological origins. The results confirm the cytotoxic activity of N(6)-isopentenyladenosine, kinetin riboside, and N(6)-benzyladenosine and show that the spectrum of cell lines that are sensitive to these compounds and their tissues of origin are wider than previously reported. The first evidence that the hydroxylated aromatic cytokinins (ortho-, meta-, para-topolin riboside) and the isoprenoid cytokinin cis-zeatin riboside have cytotoxic activities is presented. Most cell lines in the panel showed greatest sensitivity to ortho-topolin riboside (IC(50)=0.5-11.6 microM). Cytokinin nucleotides, some synthesized for the first time in this study, were usually active in a similar concentration range to the corresponding ribosides. However, cytokinin free bases, 2-methylthio derivatives and both O- and N-glucosides showed little or no toxicity. Overall the study shows that structural requirements for cytotoxic activity of cytokinins against human cancer cell lines differ from the requirements for their activity in plant bioassays. The potent anticancer activity of ortho-topolin riboside (GI(50)=0.07-84.60 microM, 1st quartile=0.33 microM, median=0.65 microM, 3rd quartile=1.94 microM) was confirmed using NCI(60), a standard panel of 59 cell lines, originating from nine different tissues. Further, the activity pattern of oTR was distinctly different from those of standard anticancer drugs, suggesting that it has a unique mechanism of activity. In comparison with standard drugs, oTR showed exceptional cytotoxic activity against NCI(60) cell lines with a mutated p53 tumour suppressor gene. oTR also exhibited significant anticancer activity against several tumour models in in vivo hollow fibre assays.
650    _2
$a adenosin $x analogy a deriváty $x chemie $x farmakologie $7 D000241
650    _2
$a protinádorové látky $x chemie $x farmakologie $7 D000970
650    _2
$a cytokininy $x analýza $x chemie $x metabolismus $7 D003583
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a geny p53 $x účinky léků $x genetika $7 D016158
650    _2
$a lidé $7 D006801
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a isopentenyladenosin $x analogy a deriváty $x chemie $x farmakologie $7 D007541
650    _2
$a kinetin $x chemie $x farmakologie $7 D007701
650    _2
$a molekulární struktura $7 D015394
650    _2
$a National Cancer Institute (U.S.) $7 D054547
650    _2
$a regulátory růstu rostlin $x farmakologie $7 D010937
650    _2
$a stereoizomerie $7 D013237
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
651    _2
$a Spojené státy americké $7 D014481
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zatloukal, Marek $7 xx0113001
700    1_
$a Lenobel, René
700    1_
$a Dolezal, Karel
700    1_
$a Béres, Tibor
700    1_
$a Krystof, Vladimír
700    1_
$a Spíchal, Lukáš $7 xx0123817
700    1_
$a Niemann, Percy
700    1_
$a Dzubák, Petr
700    1_
$a Džubák, Petr $7 xx0080445
700    1_
$a Strnad, Miroslav, $d 1958- $7 jn20010309068
773    0_
$w MED00003829 $t Phytochemistry $x 1873-3700 $g Roč. 71, č. 11-12 (20100601), s. 1350-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20553699 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20130520133400 $b ABA008
999    __
$a ok $b bmc $g 948378 $s 783682
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 71 $c 11-12 $d 1350-9 $e 20100601 $i 1873-3700 $m Phytochemistry $n Phytochemistry $x MED00003829
LZP    __
$a Pubmed-20120817/10/04

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...